Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance	Blood Protein Disorders, Hemic and Lymphatic Diseases, hematologic disorder, immune system disorder, immunoproliferative disorder, monoclonal gammopathy	Active, not recruiting	Phase 2	2026-07-23		NCT04614558

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Columbia University	375
Genzyme, a Sanofi Company	22

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Columbia University Irving Medical Center	New York	United States	234
Massachusetts General Hospital, Renal Associates Clinic	Boston	United States	1

Clinical trials